| Characterization of viral factors that are involved in the pathology of the immune compromised patient manifested as infections and/or tumour growth as well as analysis of potentially pathogenic gut bacteria. Analysis of the pathogenesis associated with lesion development of tissue targeted by micro-organisms. In addition, analysis of inflammatory reactions occurring during aseptic tissue injury, to biomaterial implants and (the development of) tissue engineered constructs. Intervention and prevention of pathogenic inflammatory reactions. Particular focus is on vaccine development and immune suppressive therapy. |
